Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20506 AL 20520

The Alteration of Neurogenesis and Pathological Markers in Alzheimer's Disease After Deep Brain Stimulation

Nassehi B, Kocabicak E, Temel Y, Hescham S.

Turk Neurosurg. 2022;32(4):535-548. doi: 10.5137/1019-5149.JTN.35598-21.2.

Multiscale imaging informs translational mouse modeling of neurological disease

Wang Y, LeDue JM, Murphy TH.

Neuron. 2022 Nov 16;110(22):3688-3710. doi: 10.1016/j.neuron.2022.09.006. Epub 2022 Oct 4.

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders

Shayganfard M.

Curr Pharm Biotechnol. 2022;23(4):538-551. doi: 10.2174/1389201022666210622111028.

Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease

Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R.

CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817.

Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic

Limbocker R, Errico S, Barbut D, Knowles TPJ, Vendruscolo M, Chiti F, Zasloff M.

Nat Prod Rep. 2022 Apr 20;39(4):742-753. doi: 10.1039/d1np00042j.

A Brewed Awakening: Neuropsychiatric Effects of Caffeine in Older Adults

Kim E, Robinson NM, Newman BM.

Clin Geriatr Med. 2022 Feb;38(1):133-144. doi: 10.1016/j.cger.2021.07.009.

Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease

Huo C, Wu L, Jiang Z, Yang J, Wang Z, Li Y, Qian S.

Med Chem. 2022;18(6):655-666. doi: 10.2174/1573406418666211130150821.

The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia

Hijazi Z, Yassi N, O'Brien JT, Watson R.

Eur J Neurol. 2022 Apr;29(4):1254-1265. doi: 10.1111/ene.15211. Epub 2022 Jan 20.

Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease

Markulin I, Matasin M, Turk VE, Salković-Petrisic M.

J Neural Transm (Vienna). 2022 Jun;129(5-6):773-804. doi: 10.1007/s00702-021-02457-2. Epub 2022 Jan 4.

Current understandings and perspectives of petroleum hydrocarbons in Alzheimer's disease and Parkinson's disease: a global concern

Rajendran R, Ragavan RP, Al-Sehemi AG, Uddin MS, Aleya L, Mathew B.

Environ Sci Pollut Res Int. 2022 Feb;29(8):10928-10949. doi: 10.1007/s11356-021-17931-3. Epub 2022 Jan 9.

MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview

Khezri MR, Yousefi K, Zolbanin NM, Ghasemnejad-Berenji M.

Mol Neurobiol. 2022 Mar;59(3):1589-1603. doi: 10.1007/s12035-022-02727-4. Epub 2022 Jan 9.

Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia

Koga S, Murakami A, Josephs KA, Dickson DW.

Neuropathology. 2022 Feb;42(1):82-89. doi: 10.1111/neup.12780. Epub 2022 Jan 13.

A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities

Panda SP, Soni U.

Ageing Res Rev. 2022 Mar;75:101560. doi: 10.1016/j.arr.2022.101560. Epub 2022 Jan 11.

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods

Udayar V, Chen Y, Sidransky E, Jagasia R.

Trends Neurosci. 2022 Mar;45(3):184-199. doi: 10.1016/j.tins.2021.12.004. Epub 2022 Jan 13.

Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review

Golubev AG.

Ageing Res Rev. 2022 Mar;75:101570. doi: 10.1016/j.arr.2022.101570. Epub 2022 Jan 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias